aTyr Pharma, Inc. (ATYR) — Stock Score Summary

aTyr Pharma, Inc. (ATYR) has a MoatMap StockRank of 2/100 based on Quality (21/100), Value (40/100), and Momentum (12/100) factor scores. The current signal is STRONG SELL.

Key Financial Metrics

Price$0.49
Market Cap$82M
P/E (Forward)-0.76
Price/Book0.82
Return on Equity-105.6%
Return on Invested Capital-99.7%
Debt/Equity20.26
Gross Margin0.0%
Operating Margin-38573.7%
Free Cash Flow$-33M

aTyr Pharma, Inc. operates in the Biotechnology industry, part of the Healthcare sector (United States).

Frequently Asked Questions

What is aTyr Pharma, Inc.’s (ATYR) StockRank?
MoatMap’s StockRank for aTyr Pharma, Inc. (ATYR) is 2/100, with a Strong Sell signal. It is a composite of Quality (21), Value (40), and Momentum (12) factor ranks across MoatMap’s 19,000+ stock universe.
Does aTyr Pharma, Inc. have an economic moat?
aTyr Pharma, Inc. (ATYR) has a Quality factor score of 21/100. The Quality factor combines ROIC, Piotroski F-Score, and leverage — the financial fingerprints of a durable competitive advantage. A Quality score above 70 typically indicates a company with the characteristics of a moated business.
Is aTyr Pharma, Inc. a buy, hold, or sell?
MoatMap’s current signal for aTyr Pharma, Inc. (ATYR) is Strong Sell, based on a StockRank of 2/100. Signals are derived mechanically from the StockRank composite and should be one input among many — combine with your own thesis on management, competitive position, and valuation.
What sector is aTyr Pharma, Inc. in?
aTyr Pharma, Inc. (ATYR) operates in the Healthcare sector, specifically the Biotechnology industry (United States).